Back to Search

HANNAH FINE, DO

DO

Neuromusculoskeletal Medicine & OMM Physician

NPI: 1528231636Individual

Specialties, Licenses & Credentials

Neuromusculoskeletal Medicine & OMM PhysicianPrimary

Neuromusculoskeletal Medicine & OMM

Code: 204D00000X

DO164332(OR)

Research & Publications (20)

Acute posterior multifocal placoid pigment epitheliopathy following varicella vaccination.
PMID 18728052·Br J Ophthalmol·2010
5-case
Glioma stem cells: not all created equal.
PMID 19345322·Cancer Cell·2009
7-preclinical
Acute zonal occult outer retinopathy in patients with multiple evanescent white dot syndrome.
PMID 19139340·Arch Ophthalmol·2009
5-case
Bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization in multifocal choroiditis.
PMID 18784620·Retina·2009
5-case
Toxic epidermal necrolysis induced by sulfonamide eyedrops.
PMID 18812774·Cornea·2008
5-case
Outcomes of 77 consecutive cases of 23-gauge transconjunctival vitrectomy surgery for posterior segment disease.
PMID 17544779·Ophthalmology·2007
8-other
A phase I trial of lenalidomide in patients with recurrent primary central nervous system tumors.
PMID 18056189·Clin Cancer Res·2007
3-trial
Bilateral cryptococcal choroiditis.
PMID 15534144·Arch Ophthalmol·2004
5-case
Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas.
PMID 12805330·J Clin Oncol·2003
3-trial
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas.
PMID 10673511·J Clin Oncol·2000
3-trial
Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.
PMID 19562255·J Neurooncol·2010
3-trial
Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial.
PMID 19636006·J Clin Oncol·2009
3-trial
SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma.
PMID 19427293·Cell Stem Cell·2009
7-preclinical
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).
PMID 19293394·Neuro Oncol·2009
3-trial
A phase I trial of enzastaurin in patients with recurrent gliomas.
PMID 19417015·Clin Cancer Res·2009
3-trial
Common variation in genes related to innate immunity and risk of adult glioma.
PMID 19423540·Cancer Epidemiol Biomarkers Prev·2009
8-other
Glioma stem cells: better flat than round.
PMID 19497271·Cell Stem Cell·2009
7-preclinical
Cellular origin of fundus autofluorescence in patients and mice with a defective NR2E3 gene.
PMID 19429590·Br J Ophthalmol·2009
5-case
Intravitreal injection of tissue plasminogen activator as treatment for an occluded pars plana glaucoma tube.
PMID 19668550·Clin Ophthalmol·2009
5-case
Corneal verticillata after dual anti-epidermal growth factor receptor and anti-vascular endothelial growth factor receptor 2 therapy (vandetanib) for anaplastic astrocytoma.
PMID 19512898·Cornea·2009
5-case

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via practice · 2 locations total

Address
534 PLEASANT VIEW WAY NW, SUITE 100
ALBANY, OR 97321

Locations (2)

Practice Location

534 PLEASANT VIEW WAY NW, ALBANY, OR
(541) 812-5656

Practice Location

1007 HARLOW RD STE 310, SPRINGFIELD, OR
(541) 463-2280

Quick Facts

NPI
1528231636
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
2
Publications
20

Are you this provider?

Claim Your Profile